New drug trial offers hope for ulcerative colitis patients
NCT ID NCT07335055
Summary
This study is testing whether an investigational drug called HSK47388 can help control symptoms and reduce inflammation in adults with moderate to severe ulcerative colitis. Researchers will compare HSK47388 against a placebo in about 150 participants whose current treatments aren't working well enough. The goal is to see if the drug is effective and safe for managing this chronic bowel disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sir Run Run Shaw Hospital
RECRUITINGHangzhou, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.